Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for G52441105 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 2 | 8.5% |
8/14/2026
Event 6/30/2026
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 1 | 10.2% |
4/8/2026
Event 3/31/2026
|
|
|
Endeavour Medtech Growth II LP
13G/A
Amendment 1
|
4.2% |
2/17/2026
Event 12/31/2025
|
|
| Endeavour Medtech Growth II LP | 4.2% | ||
| Endeavour Medtech Growth II Parallel LP | 4.2% | ||
| Endeavour Medtech II GP Limited | 4.2% | ||
| Bain Charger Holdings, L.P. 13G/A Amendment 1 | 43.1% |
2/17/2026
Event 12/31/2025
|
|
| Price T Rowe Associates Inc /MD/ 13G | 7.5% |
2/17/2026
Event 12/31/2025
|
|
|
FMR LLC
13G/A
Amendment 1
|
10.2% |
10/7/2025
Event 9/30/2025
|
|
| FMR LLC | 10.2% | ||
| Abigail P. Johnson | 10.2% | ||
| Bain Charger Holdings, L.P. 13G | 52.6% |
5/15/2025
Event 3/31/2025
|
|
|
Endeavour Medtech Growth II LP
13G
|
5.2% |
5/15/2025
Event 3/31/2025
|
|
| Endeavour Medtech Growth II LP | 5.2% | ||
| Endeavour Medtech Growth II Parallel LP | 5.2% | ||
| Endeavour Medtech II GP Limited | 5.2% | ||
|
FMR LLC
13G
|
6.3% |
5/12/2025
Event 3/31/2025
|
|
| FMR LLC | 6.3% | ||
| Abigail P. Johnson | 6.3% |